代谢相关脂肪性肝病临床科研与疾病管理大数据共享平台

Clinical research and disease management data platform MASLD

搜索
论文标题 作者 发表时间 发表杂志 影响因子
The Protective Effect of FOXO3 rs2802292 G-Allele on Food Intake in a Southern Italian Cohort Affected by MASLD

Rossella Donghia, Elisabetta Di Nicola, Rossella Tatoli, Giovanna Forte, Martina Lepore Signorile, Caterina Bonfiglio, Marialaura Latrofa, Katia De Marco, Andrea Manghisi, Vittoria Disciglio, Candida Fasano, Paola Sanese, Filomena Cariola, Antonia Lucia Buonadonna, Gianluigi Giannelli, Valentina Grossi, Cristiano Simone.

2025-04

Nutrients

4.8

The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity

Sofia Tamini, Adele Bondesan, Diana Caroli, Nicoletta Marazzi, Alessandro Sartorio.

2025-03

Journal of clinical medicine

3.0

Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment

Zisis M, Chondrogianni ME, Androutsakos T, Rantos I, Oikonomou E, Chatzigeorgiou A, Kassi E.

2025-02

Biomolecules

4.8

Full-length 16S rRNA Sequencing Reveals Gut Microbiome Signatures Predictive of MASLD in children with obesity

Yu-Cheng Lin, Chi-Chien Wu, Yun-Er Li, Chun-Liang Chen, Chia-Ray Lin, Yen-Hsuan Ni

2025-03

BMC Microbiology

4

Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbidities

Tom Ryu, Young Chang, Jeong-Ju Yoo, Sae Hwan Lee Soung Won Jeong, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Keungmo Yang, Jae Young Jang

2025-02

Clinical nutrition

6.6

Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

Crane H, Eslick GD, Gofton C, Shaikh A, Cholankeril G, Cheah M, Zhong JH, Svegliati-Baroni G, Vitale A, Kim BK, Ahn SH, Kim MN, Strasser SI, George J.

2024-04

Clinical and molecular hepatology

14

Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.

Younossi ZM, Paik JM, Stepanova M, Ong J, Alqahtani S, Henry L.

2024-01

Journal of hepatology

26.8

A High-Fat and High-Fructose Diet Exacerbates Liver Dysfunction by Regulating Sirtuins in a Murine Model

Ding Z, Zhang J, Choudhury M.

2024-06

Life (Basel, Switzerland)

3.2

Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux

Chen X, Chen S, Pang J, Huang R, You Y, Zhang H, Xiao J, Xue H, Ling W

2023-09

Journal of hepatology

26.8

TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase

Xu S, Wu X, Wang S, Xu M, Fang T, Ma X, Chen M, Fu J, Guo J, Tian S, Tian T, Cheng X, Yang H, Zhou J, Wang Z, Yin Y, Xu W, Xu F, Yan J, Wang Z, Luo S, Zhang XJ, Ji YX, Weng J.

2024-01

The Journal of clinical investigation

13.3

1 2 3 4 5 6 7 8 9 10 11